在阿尔茨海默病中发现药物的查技术
Sandra Maniam1, Subashani Maniam2
1Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor Darul Ehsan, Malaysia.
ACS omega
|February 19, 2024
概括
本综述总结了针对阿尔茨海默病 (AD) 途径的小分子,如粉样β和. 它强调了新的查方法,以推进这种神经退行性疾病的药物发现.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响记忆和认知.
- 关键的病理途径包括粉样β神经毒性,病原体和神经炎症.
- 驱动AD进展的精确分子机制仍然不完全理解.
研究的目的:
- 审查旨在准主要阿尔茨海默氏症疾病途径的小分子.
- 突出在AD药物发现中使用的先进查技术.
- 概述当前针对AD的小分子治疗方法的研究.
主要方法:
- 文献综述侧重于小分子抑制剂和调制剂.
- 分析各种药物发现技术,包括高通量选.
- 检查分子建模,定制生物测试和光谱检测工具.
主要成果:
- 识别针对粉样β,和神经炎症通路的各种小分子.
- 讨论当前治疗小分子的疗效和局限性.
- 概述新兴的查方法,提高药物发现效率.
结论:
- 针对关键AD途径的小分子代表了治疗发展的重要领域.
- 先进的查方法对于加速发现新的AD治疗方法至关重要.
- 需要进一步的研究来阐明明确定的分子机制,并开发有效的疗法.
相关概念视频
01:22Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
01:26Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484